Biotech Collaborations Accelerate Botulinum Toxin Product Innovation
The global botulinum toxin CDMO market size was estimated at USD 2.5 billion in 2025 and is projected to reach USD 5.8 billion by 2033, growing at a CAGR of 11.5% from 2026 to 2033. The market is experiencing significant momentum as pharmaceutical and biotechnology companies increasingly rely on contract development and manufacturing organizations (CDMOs) to streamline production, enhance...
0 Comentários 0 Compartilhamentos 40 Visualizações 0 Anterior
Patrocinado
Myliveroom — Live Events & Online Communities https://myliveroom.com